FDA Approved: PERSERIS — Supplemental Application (Indivior Inc.)

View source ↗

Summary

FDA approved a supplemental application for Perseris (risperidone) filed by Indivior Inc. Perseris is a long-acting injectable antipsychotic formulation of risp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• PERSERIS (RISPERIDONE)

Snippet

SUPPL AP for PERSERIS (RISPERIDONE)